Universidad de Salamanca-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2024

  1. Exploring the role of ribosomal RNA modifications in cancer

    Current Opinion in Genetics and Development, Vol. 86

  2. The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues

    NAR Cancer, Vol. 6, Núm. 1

2023

  1. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  2. N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer

    Oncogene, Vol. 42, Núm. 43, pp. 3169-3181

2022

  1. Epigenetic and Epitranscriptomic Control in Prostate Cancer

    Genes, Vol. 13, Núm. 2

2021

  1. A therapy PUSh for GBM

    Nature Cancer, Vol. 2, Núm. 9, pp. 876-878

2020

  1. Emerging roles of novel small non-coding regulatory RNAs in immunity and cancer

    RNA Biology, Vol. 17, Núm. 8, pp. 1196-1213

  2. Glia Crosstalk in Neuroinflammatory Diseases

    Frontiers in Cellular Neuroscience, Vol. 14

2019

  1. Cytosine-5 RNA methylation links protein synthesis to cell metabolism

    PLoS Biology, Vol. 17, Núm. 6

  2. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

    Acta Neuropathologica, Vol. 138, Núm. 6, pp. 1053-1074

  3. Post-transcriptional regulation by cytosine-5 methylation of RNA

    Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, Vol. 1862, Núm. 3, pp. 240-252

2014

  1. Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting dna damage response

    Oncotarget, Vol. 5, Núm. 7, pp. 1770-1778

2012

  1. VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling

    Cellular and Molecular Life Sciences, Vol. 69, Núm. 22, pp. 3881-3893

2009

  1. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer

    Human Molecular Genetics, Vol. 18, Núm. 7, pp. 1343-1352

2008

  1. Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein

    PLoS ONE, Vol. 3, Núm. 2

  2. The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53

    PLoS ONE, Vol. 3, Núm. 7

2007

  1. Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1

    Molecular and Cellular Biology, Vol. 27, Núm. 20, pp. 7273-7283

2006

  1. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines

    FEBS Journal, Vol. 273, Núm. 11, pp. 2487-2504

  2. VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma

    Molecular Cancer Research, Vol. 4, Núm. 3, pp. 177-185

  3. Vaccinia virus B1R kinase interacts with JIP1 and modulates c-Jun-dependent signaling

    Journal of Virology, Vol. 80, Núm. 15, pp. 7667-7675